Vitamin B12 (Cobalamin)

What is Vitamin B12 (Cobalamin)?

Vitamin B12 supports nerve function and red blood cell formation.

Vitamin B12, or cobalamin, is a nutrient your body needs to make red blood cells, maintain the protective sheath around nerves, and build DNA. Unlike most vitamins, it comes almost entirely from animal products, so people who eat little or no meat, eggs, or dairy are one of the few groups who can become deficient purely from diet, according to the National Institutes of Health Office of Dietary Supplements (reviewed July 2, 2025). For most people, though, deficiency isn't a diet problem. It's an absorption problem, and the mechanics of that absorption explain why B12 testing is more complicated than a single number suggests. Dietary B12 first binds to a stomach protein and then, in the small intestine, has to attach to intrinsic factor, a protein made by cells lining the stomach, before the body can absorb it in the final segment of the small intestine. Anything that reduces stomach acid, damages the stomach lining, or destroys those intrinsic-factor-producing cells can block this chain and cause deficiency even when someone eats plenty of B12. The most direct cause is pernicious anemia, an autoimmune condition where the immune system attacks either the stomach cells that make intrinsic factor or intrinsic factor itself, so B12 can no longer be absorbed regardless of intake. It typically develops in adulthood, most often around age 60, and while it was first described in people of Northern European descent, it occurs across all ethnic groups, according to a 2026 clinical overview. Two other well-documented causes are common medications: long-term metformin use and long-term acid-suppressing drugs. A 2025 analysis of the NIH's All of Us research program, covering nearly 15,000 adults with type 2 diabetes, found that people on metformin for four or more years had a 67% higher likelihood of B12 deficiency than non-users, with peripheral neuropathy also more common in long-term users. Separately, a landmark JAMA case-control study of over 200,000 people found that two or more years of proton pump inhibitor use was linked to a 65% higher risk of B12 deficiency, and H2 blockers to a 25% higher risk, with higher PPI doses carrying more risk. A more recent 2026 cohort from Saudi Arabia tracking PPI users directly found B12 deficiency prevalence rose from 8.2% to 12.2% after six or more months of therapy. The test itself has a well-known blind spot. Standard "total B12" blood tests measure all the B12 circulating in your blood, but only about 20-30% of that is bound to transcobalamin, the carrier protein that actually delivers B12 into your cells. The rest is bound to a different carrier, haptocorrin, that doesn't make B12 available for cellular use, according to NHS laboratory guidance. That means a total B12 result can look reassuring while cellular-level B12 is still short, or can dip for reasons unrelated to true deficiency. This is the mechanical reason a "normal" total B12 result doesn't fully rule deficiency out, and why functional markers like methylmalonic acid and active B12 (holotranscobalamin) exist as follow-up tests. Each has its own page that covers it in more depth. Longetic doesn't diagnose or monitor B12 deficiency. What it does is keep every B12 result you've ever had, from whichever lab or clinic ran it, in one searchable place, so you and your doctor can see the pattern over time instead of comparing a single new PDF against memory.

Typical reference context

Reference ranges vary by lab and assay, so treat these as context, not a verdict on any individual result. The National Institutes of Health lists a typical laboratory range for total B12 of roughly 200 to 900 pg/mL (about 150-665 pmol/L), with results under about 200-250 pg/mL flagged as low. The UK's National Institute for Health and Care Excellence (NICE) published more specific interpretation bands in its March 2024 guideline, shown in the table above.

That middle band is the gray zone: a large share of people with genuine functional B12 deficiency fall inside it, which is exactly why NICE recommends a follow-up methylmalonic acid test for anyone in that range who has symptoms, rather than treating an indeterminate result as reassuring on its own. One practical note worth knowing before testing: high-dose biotin (vitamin B7) supplements, common in hair, skin, and nail products, can interfere with the immunoassay method used for total B12 testing and skew results, according to a 2017 FDA safety communication that's still the standard reference on the issue.

What changed recently

The clearest recent development is NICE's March 2024 guideline on vitamin B12 deficiency in adults, the first UK national guidance to formally define the indeterminate "gray zone" for total and active B12 testing and to recommend reflex methylmalonic acid testing for indeterminate results in symptomatic people, rather than leaving clinicians to interpret borderline numbers case by case. A 2025 paper in the European Journal of Clinical Nutrition has since argued the guideline still leaves gaps in how pernicious anemia specifically gets recognized and diagnosed, suggesting this is an area likely to keep evolving. On the medication side, the 2025 All of Us metformin analysis is the largest and most recent look at long-term metformin's B12 effect, and it found the deficiency risk climbed by about 3% for every additional year on the drug after a diabetes diagnosis, reinforcing why several diabetes and endocrine groups already recommend periodic B12 checks for long-term metformin users.

Tests often checked alongside this

Methylmalonic Acid (MMA) rises specifically when cells lack usable B12, making it the standard follow-up test for indeterminate or borderline B12 results. Holotranscobalamin (Active B12) measures only the transcobalamin-bound, cell-usable fraction of B12, rather than the total pool. Folate (Serum) is checked together with B12 since folate and B12 deficiency can produce similar blood changes. Homocysteine rises with either B12 or folate deficiency, since both vitamins are needed to clear it from the blood. Intrinsic factor antibodies: a positive result supports a diagnosis of pernicious anemia, the autoimmune cause of B12 malabsorption described above.

What can affect this marker

Diet plays a role since B12 comes mainly from animal products, so low intake is a real, if less common, cause, particularly for people eating vegan or largely plant-based. Absorption problems matter too: atrophic gastritis, which reduces stomach acid and intrinsic factor production, affects an estimated 8-9% of adults over 65. Bariatric surgery, procedures that bypass or remove part of the stomach, reduces both stomach acid and intrinsic factor production, so B12 deficiency is a recognized long-term risk. Metformin and long-term acid-suppressing medication are both independently associated with higher deficiency risk over months to years of use. Biotin supplements taken before testing can also distort total B12 immunoassay results in either direction.

What to ask your doctor

• Where does my result fall relative to the lab's reference range, and would a follow-up test like MMA or active B12 add clarity?
• Could any medication I'm taking, including metformin or long-term acid reducers, be affecting this result?
• Is there a reason to check for pernicious anemia specifically, such as an intrinsic factor antibody test?
• If a result is being rechecked, how long should I wait, and is there anything I should pause beforehand, such as biotin supplements?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.

Frequently asked questions